Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Hemolytic, Autoimmune (Phase 3)
Antineoplastic Combined Chemotherapy Protocols (Phase 1/Phase 2)
Breast Neoplasms (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Colorectal Neoplasms (Phase 1)
Drug Therapy (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 1)
Head and Neck Neoplasms (Phase 1)
Hodgkin Disease (Phase 2)
Leukemia, B-Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1/Phase 2)
Melanoma (Phase 1)
Mycosis Fungoides (Phase 1)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1)
Pemphigus (Phase 2)
Phosphatidylinositol 3-Kinases (Phase 1/Phase 2)
Polycythemia Vera (Phase 3)
Primary Myelofibrosis (Phase 3)
Sjogren's Syndrome (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue